All In MedTech

FDA Clearance Tracker · P970004-S302

InterStim Therapy System and Verify Evaluation System (SNS Urinary Programming Systems)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 30, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 30, 2020

Approved

Time to decision

297 days

Received Oct 7, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970004-S302
Device name
InterStim Therapy System and Verify Evaluation System (SNS Urinary Programming Systems)
Applicant location
Minneapolis, MN
Received
Oct 7, 2019
Decided
Jul 30, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P970004

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code EZW

FDA's approval statement

As written in FDA's record.

Approval of the new InterStim Micro System with 1.5T and 3T full-body MR conditional labeling, an updated InterStim II System (including new SureScan MRI leads) with 1.5T and 3T full-body MR conditional labeling, an updated Verify Evaluation System that can accommodate newly developed leads, and related labeling updates.

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.